Show simple item record

dc.contributor.authorDeligianni, Elena
dc.contributor.authorDaniel, Omari-Jordan
dc.contributor.authorCorkery, John
dc.contributor.authorSchifano, Fabrizio
dc.contributor.authorLione, Lisa
dc.date.accessioned2019-09-17T14:04:24Z
dc.date.available2019-09-17T14:04:24Z
dc.date.issued2019-09-08
dc.identifier.citationDeligianni , E , Daniel , O-J , Corkery , J , Schifano , F & Lione , L 2019 , ' Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of Novel Psychoactive Substances ' , British Journal of Clinical Pharmacology . https://doi.org/10.1111/bcp.14123
dc.identifier.issn0306-5251
dc.identifier.otherPURE: 17344011
dc.identifier.otherPURE UUID: 33cbc8d1-04b9-49dd-b4b7-2867c5347b0d
dc.identifier.urihttp://hdl.handle.net/2299/21684
dc.description© 2019 The British Pharmacological Society.
dc.description.abstractAims: The risk of potential harms prompted the UK government to introduce the Psychoactive Substances Act (PSA) in 2016. The aim of the present study was to evaluate the impact and effectiveness of this new legislation on patterns of NPS awareness, use, experiences and risk awareness in a self-selected sample of UK consumers to inform education and policy. Methods: The Bristol Online Survey was advertised on the Bluelight drug forum and social media Facebook pages and University email between 7 January and 7 February 2015 (168 responses) and 9 March to 18 September 2017 (726 responses). UK country of residence responses were extracted for analysis (SPSS). Results: In a predominantly university-educated, young (< 25 years) self-selecting sample, one year after introduction of the legislation, NPS use (in males, under 18s, those educated to school/college level, p<0.001) has increased, whilst health risk awareness has not changed and remains poor. Users are switching to sourcing NPS via street dealers (49%) and the darknet (31%) and showing an increase in preference for the herbal NPS Salvia divinorum (p<0.05). The main reasons for NPS use remain the influence of friends (69%) in a social setting and to ‘get high’ (76%) usually in combination with alcohol, cannabis or ecstasy. Conclusions: Regulation alone, so far, has not impacted on health risk awareness, NPS drug demand and culture in our UK survey sample. Alongside regulation, NPS health promotion education (particularly in schools, colleges) is needed that addresses resilience and both the risks and beneficial effects of NPS.en
dc.language.isoeng
dc.relation.ispartofBritish Journal of Clinical Pharmacology
dc.subjectNovel Psychoactive Substances (NPS)
dc.subjectonline survey
dc.subjectrecreational use
dc.subjectpolicy
dc.subjectPsychoactive Substances Act 2016
dc.subjectpsychoactive effects
dc.titleImpact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of Novel Psychoactive Substancesen
dc.contributor.institutionDepartment of Clinical and Pharmaceutical Sciences
dc.contributor.institutionCentre for Health Services and Clinical Research
dc.contributor.institutionBasic and Clinical Science Unit
dc.contributor.institutionTRP Ion channels
dc.contributor.institutionAgriculture, Veterinary and Food Sciences
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionPsychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit
dc.contributor.institutionCentre for Clinical Practice, Safe Medicines and Drug Misuse Research
dc.description.statusPeer reviewed
dc.date.embargoedUntil2020-08-29
rioxxterms.versionAM
rioxxterms.versionofrecordhttps://doi.org/10.1111/bcp.14123
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record